- Jul 17, 2022
top of page

ABOUT THE AUTHOR
I have a PhD in bio-medical anthropology became bored with Academia and repackaged my problem-solving skills to become an expert in pharmaceutical New Product Planning and Strategic Marketing that led to becoming Senior Vice President of Global Strategy for one of the top Swiss Pharma companies. In my professional role, I developed a strong interest in personalized medicine and a passion for its implementation. I was involved in a pharmaceutical company’s acquisition of a diagnostics group in the late 1990’s to accelerate implementation of personalized medicine. Recently, I wrote a business plan for the implementation of personalized medicine for a G7 country.
I’m a native of Berkeley, California, and live there today. I got my BA in anthropology from the University of California and went on to graduate school at the University of Pennsylvania, which I thought was another state school. Budding anthropologists have to choose where to do fieldwork. In my case, I looked for the amalgam of beaches, tropics, and French food. I won my personal trifecta in the then New Hebrides (now Vanuatu). I was fortunate to study with the discoverer of the hepatitis B virus.
Welcome to Elizabeth “Betsy” Aden’s Tidbits
Personalized Medicine - The Goldilocks Genome
Around 2010, I was listening an interview with Irving Weissman, a leader in stem cell biology. I was struck by his comment that fiction is how the lay public learns about science. I was frustrated with the lack of progress in personalized medicine. I wanted to write a book that combined what I loved about Michael Crichton, Dick Francis, Lawrence Sanders, and Kathy Reich novels. So, I played with the idea of using fiction to create awareness of personalized medicine. Hence the idea for The Goldilocks Genome where pharmacology and genes have a deadly collision and it takes a head-strong epidemiologist heroine to solve the puzzle.
CLICK HERE for a good introduction to the scope of personalized medicine by McKinsey Consultants
Personalized medicine, sometimes called precision medicine, has made dramatic progress in oncology, when the therapy is matched to the genotype of the tumor.
When genomic, proteomic, and metabolomic data are incorporated into an individual's medical record, patient outcomes will be better and medical costs should be reduced.
The idea for this book began with wanting to highlight our Neanderthal genetic heritage and how it affects drug metabolism. I explored a number of ways to get the importance of personalization of medicine across and first put fingers to my keyboard in 2013 in an online course with author Shelley Singer. I wrote the prologue in one sitting at my kitchen table after watching numerous YouTube videos about jumpers from the Golden Gate Bridge and then reading The Final Leap: Suicide on the Golden Gate Bridge by John Bateson. In Shelley’s course and subsequent working group, I developed my first draft which took two years to write.
bottom of page